Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) 3-Year Revenue Growth Rate : 4.50% (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Jingxin Pharmaceutical Co 3-Year Revenue Growth Rate?

Zhejiang Jingxin Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2025 was ¥1.17.

During the past 12 months, Zhejiang Jingxin Pharmaceutical Co's average Revenue per Share Growth Rate was 0.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Zhejiang Jingxin Pharmaceutical Co was 20.30% per year. The lowest was -20.90% per year. And the median was 8.30% per year.

Competitive Comparison of Zhejiang Jingxin Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jingxin Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Jingxin Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jingxin Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Jingxin Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Zhejiang Jingxin Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Zhejiang Jingxin Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Jingxin Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jingxin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jingxin Pharmaceutical Co Ltd (SZSE:002020) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

No.800 Xinchang East Road, Yulin subdistrict, Zhejiang Province, Xinchang, CHN, 312500

Website

http://www.jingxinpharm.com

Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.

Executives

Wang Neng Neng	Director
Chen Shao Bi	Executives
Wang Guang Qiang	Supervisors
Lv Gang	Director
Zhou Lin	Executives
Yu Yi Ping	Supervisors
Chen Mei Li	Directors, executives
Zhang Li Wa	Directors, executives
Wu Zheng Jie	Director

Zhejiang Jingxin Pharmaceutical Co Headlines

No Headlines